Peng Y - Search Results

1

A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma.

Yu H, Fu Y, Tang Z, Jiang L, Qu C, Li H, Tan Z, Shu D, Peng Y, Liu S. Yu H, et al. Among authors: peng y. Aging (Albany NY). 2022 Jan 27;14(2):989-1013. doi: 10.18632/aging.203855. Epub 2022 Jan 27. Aging (Albany NY). 2022. PMID: 35085103 Free PMC article.

2

A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma.

Peng Y, Yu H, Zhang Y, Qu F, Tang Z, Qu C, Tian J, Zong B, Wang Y, Ren H, Liu S. Peng Y, et al. Sci Rep. 2021 Sep 2;11(1):17610. doi: 10.1038/s41598-021-97102-z. Sci Rep. 2021. PMID: 34475496 Free PMC article.

3

JAM2 predicts a good prognosis and inhibits invasion and migration by suppressing EMT pathway in breast cancer.

Peng Y, Li H, Fu Y, Guo S, Qu C, Zhang Y, Zong B, Liu S. Peng Y, et al. Int Immunopharmacol. 2022 Feb;103:108430. doi: 10.1016/j.intimp.2021.108430. Epub 2021 Dec 17. Int Immunopharmacol. 2022. PMID: 34923424

4

Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer.

Xu Y, Shu D, Shen M, Wu Q, Peng Y, Liu L, Tang Z, Gao S, Wang Y, Liu S. Xu Y, et al. Among authors: peng y. J Immunol Res. 2022 Jun 2;2022:9412119. doi: 10.1155/2022/9412119. eCollection 2022. J Immunol Res. 2022. PMID: 35692496 Free PMC article.

5

Development and validation of a novel 15-CpG-based signature for predicting prognosis in triple-negative breast cancer.

Peng Y, Shui L, Xie J, Liu S. Peng Y, et al. J Cell Mol Med. 2020 Aug;24(16):9378-9387. doi: 10.1111/jcmm.15588. Epub 2020 Jul 10. J Cell Mol Med. 2020. PMID: 32649035 Free PMC article.

6

Development of a Prognostic Model Based on Pyroptosis-Related Genes in Pancreatic Adenocarcinoma.

Su K, Peng Y, Yu H. Su K, et al. Among authors: peng y. Dis Markers. 2022 May 29;2022:9141117. doi: 10.1155/2022/9141117. eCollection 2022. Dis Markers. 2022. PMID: 35677632 Free PMC article.

7

Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer.

Peng Y, Yu H, Jin Y, Qu F, Ren H, Tang Z, Zhang Y, Qu C, Zong B, Liu S. Peng Y, et al. Front Immunol. 2021 Apr 27;12:666137. doi: 10.3389/fimmu.2021.666137. eCollection 2021. Front Immunol. 2021. PMID: 33986754 Free PMC article.

8

Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy.

Lan A, Jin Y, Wang Y, Wang Y, Ding N, Dai Y, Jiang L, Tang Z, Peng Y, Liu S. Lan A, et al. Among authors: peng y. Int J Clin Oncol. 2022 May;27(5):899-910. doi: 10.1007/s10147-022-02141-9. Epub 2022 Mar 3. Int J Clin Oncol. 2022. PMID: 35239089

9

Liu L, Chen C, Tu G, Peng Y, Shen M, Xu Y, Liu S. Liu L, et al. Among authors: peng y. Front Cell Dev Biol. 2022 Mar 4;10:821727. doi: 10.3389/fcell.2022.821727. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35309942 Free PMC article.

10

Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer Patients.

Xu Y, Peng Y, Shen M, Liu L, Lei J, Gao S, Wang Y, Lan A, Li H, Liu S. Xu Y, et al. Among authors: peng y. J Oncol. 2022 Apr 20;2022:1525245. doi: 10.1155/2022/1525245. eCollection 2022. J Oncol. 2022. PMID: 35498539 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,180 results

Search Page

Filters